Integer Holdings Corp. (ITGR)
72.34
+0.39
(+0.54%)
USD |
NYSE |
Dec 11, 16:00
72.06
-0.28
(-0.39%)
Pre-Market: 07:09
Integer Holdings Research and Development Expense (TTM): 50.00M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 1.943B |
| Masimo Corp. | 172.00M |
| Perspective Therapeutics, Inc. | 61.22M |
| Xtant Medical Holdings, Inc. | 2.165M |
| VolitionRX Ltd. | 9.144M |